Carotid Intima-Media Thickness and the Risk of Sudden Cardiac Death: The ARIC Study and the CHS.
Carotid Intima‐Media Thickness
Epidemiology
Sudden Cardiac Death
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
20 10 2020
20 10 2020
Historique:
pubmed:
26
9
2020
medline:
16
3
2021
entrez:
25
9
2020
Statut:
ppublish
Résumé
Background Sudden cardiac death (SCD) is associated with severe coronary heart disease in the great majority of cases. Whether carotid intima-media thickness (C-IMT), a known surrogate marker of subclinical atherosclerosis, is associated with risk of SCD in a general population remains unknown. The objective of this study was to investigate the association between C-IMT and risk of SCD. Methods and Results We examined a total of 20 862 participants: 15 307 participants of the ARIC (Atherosclerosis Risk in Communities) study and 5555 participants of the CHS (Cardiovascular Health Study). C-IMT and common carotid artery intima-media thickness was measured at baseline by ultrasound. Presence of plaque was judged by trained readers. Over a median of 23.5 years of follow-up, 569 participants had SCD (1.81 cases per 1000 person-years) in the ARIC study. Mean C-IMT and common carotid artery intima-media thickness were associated with risk of SCD after adjustment for traditional risk factors and time-varying adjustors: hazard ratios (HRs) with 95% CIs for fourth versus first quartile were 1.64 (1.15-2.63) and 1.49 (1.05-2.11), respectively. In CHS, 302 participants developed SCD (4.64 cases per 1000 person-years) over 13.1 years. Maximum C-IMT was associated with risk of SCD after adjustment: HR (95% CI) for fourth versus first quartile was 1.75 (1.22-2.51). Presence of plaque was associated with 35% increased risk of SCD: HR (95% CI) of 1.37 (1.13-1.67) in the ARIC study and 1.32 (1.04-1.68) in CHS. Conclusions C-IMT was associated with risk of SCD in 2 biracial community-based cohorts. C-IMT may be used as a marker of SCD risk and potentially to initiate early therapeutic interventions to mitigate the risk.
Identifiants
pubmed: 32975158
doi: 10.1161/JAHA.120.016981
pmc: PMC7792412
doi:
Types de publication
Journal Article
Observational Study
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e016981Subventions
Organisme : NHLBI NIH HHS
ID : HHSN268201100008C
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85080
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG023629
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85082
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC55222
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85086
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100012C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100005C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100009C
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85081
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100010C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800001C
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL080295
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100007C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201200036C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100011C
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL130114
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85079
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85083
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100006C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268200800007C
Pays : United States
Références
Am J Epidemiol. 1989 Apr;129(4):687-702
pubmed: 2646917
Stroke. 2011 Nov;42(11):3075-9
pubmed: 21940954
Ann Epidemiol. 1991 Feb;1(3):263-76
pubmed: 1669507
Europace. 2006 Sep;8(9):746-837
pubmed: 16935866
Am Heart J. 2010 Jan;159(1):33-9
pubmed: 20102864
Circulation. 2015 Jan 27;131(4):e29-322
pubmed: 25520374
Am J Cardiol. 2008 Apr 1;101(7):1016-22
pubmed: 18359324
Biomed Pharmacother. 2005 Oct;59 Suppl 1:S49-53
pubmed: 16275507
Circ Heart Fail. 2008 Nov;1(4):242-8
pubmed: 19808298
Eur Heart J. 2017 Jun 7;38(22):1717-1727
pubmed: 27252448
J Am Coll Cardiol. 2012 Dec 25;60(25):2674-82
pubmed: 23177296
Ann Intern Med. 2001 Jan 2;134(1):12-20
pubmed: 11187415
Echocardiography. 2009 Aug;26(7):785-800
pubmed: 19552673
Circulation. 2006 Apr 18;113(15):1842-8
pubmed: 16618831
J Am Heart Assoc. 2020 Oct 20;9(19):e016981
pubmed: 32975158
Eur Heart J. 2012 Jan;33(2):183-90
pubmed: 21666250
Ann Epidemiol. 1995 Jul;5(4):278-85
pubmed: 8520709
Circulation. 2014 Jan 28;129(4):516-26
pubmed: 24470473
Ann Epidemiol. 1995 Jul;5(4):270-7
pubmed: 8520708
J Am Coll Cardiol. 2010 Apr 13;55(15):1600-7
pubmed: 20378078
N Engl J Med. 1999 Jan 7;340(1):14-22
pubmed: 9878640
J Am Coll Cardiol. 2004 Jun 16;43(12):2236-41
pubmed: 15193686
Circulation. 2002 Jun 4;105(22):2595-9
pubmed: 12045163
Heart. 2017 Mar;103(5):383-389
pubmed: 27604814
Stroke. 2012 Jan;43(1):103-8
pubmed: 22033999
Eur Heart J. 2000 Jun;21(11):919-26
pubmed: 10806016
Circulation. 2018 Mar 20;137(12):e67-e492
pubmed: 29386200
Trends Cardiovasc Med. 2016 Jan;26(1):23-33
pubmed: 25957808
Am J Epidemiol. 1997 Sep 15;146(6):483-94
pubmed: 9290509
J Am Coll Cardiol. 2010 Oct 26;56(18):1476-83
pubmed: 20951323
Stroke. 1994 Dec;25(12):2377-83
pubmed: 7974576
Heart Rhythm. 2013 Oct;10(10):1425-32
pubmed: 23906927